Former CMR Surgical CEO Joins Nanoflex Robotics Board

Nanoflex Robotics has appointed former CMR Surgical CEO Per Vegard Nerseth to its board as an independent non-executive director.

“We are thrilled to welcome Per Vegard to our board. His extensive leadership experience and deep understanding of complex regulatory markets will be invaluable to Nanoflex Robotics as we aim to complete our first-in-human procedures next year and commence clinical studies thereafter,” Nanoflex Robotics CEO Matt Curran said.
 
Per Vegard has more than three decades of global business experience, including developing high-performing teams and launching new ventures in the robotics sector. Most recently, Per Vegard was CEO and board member at CMR Surgical; before that, he held multiple portfolios at ABB, where he steered business lines’ turnarounds and optimized for long-term strategic growth.

Per Vegard’s track record of navigating complex markets and scaling cutting-edge technologies makes him a crucial addition to Nanoflex Robotics’s board, according to company executives. His expertise is especially valuable as the company looks to accelerate the development of its telerobotics system to treat acute ischemic stroke and bring it to market.

---

READ MORE: Nanoflex Robotics’ Remote-Ready System Enters North American Market

---

 
“I am honored to join the board of Nanoflex Robotics. I admire the company’s vision in developing a telerobotic platform to treat acute ischemic stroke. I look forward to contributing to the company’s future success and working with such the team,” Nerseth stated.
 
Nanoflex Robotics is a Swiss medical device startup that aims to enhance accessibility to life-saving interventions through telerobotics. The first application of the company’s Remote Intervention System (RIS) is to enable a remote thrombectomy for patients suffering from acute ischemic stroke. The RIS is currently undergoing final product refinement and pre-clinical testing with the aim of conducting its first-in-human procedure in 2025.
 
Nanoflex Robotics is building a next-generation telerobotics interventional platform to enhance access to life-saving procedures. The first target application of the Remote Intervention System (RIS) is to enable telerobotic mechanical thrombectomies in acute ischemic stroke patients where timely intervention is critical. The RIS combines unique advanced magnetic navigation technology and ultra-flexible endoluminal robotic tools to give physicians greater control and dexterity over procedures, allowing for safer and more precise interventions that enhance patient care, reduce complications, and improve overall outcomes.